Related references
Note: Only part of the references are listed.Adjuvant treatment of colon cancer with microsatellite instability - the state of the art
Ester Oneda et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2022)
Identification of a highly efficient dual type I/II FMS-like tyrosine kinase inhibitor that disrupts the growth of leukemic cells
Mandy Beyer et al.
CELL CHEMICAL BIOLOGY (2022)
Class 1 Histone Deacetylases and Ataxia-Telangiectasia Mutated Kinase Control the Survival of Murine Pancreatic Cancer Cells upon dNTP Depletion
Alexandra Nguyen et al.
CELLS (2021)
5-fluorouracil and other fluoropyrimidines in colorectal cancer: Past, present and future
Sona Vodenkova et al.
PHARMACOLOGY & THERAPEUTICS (2020)
Mechanism of colorectal carcinogenesis triggered by heme iron from red meat
Nina Seiwert et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2020)
Principles and mechanisms of non-genetic resistance in cancer
Charles C. Bell et al.
BRITISH JOURNAL OF CANCER (2020)
Epigenetics of colorectal cancer: biomarker and therapeutic potential
Gerhard Jung et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)
Inhibition of the ATR kinase enhances 5-FU sensitivity independently of nonhomologous end-joining and homologous recombination repair pathways
Soichiro S. Ito et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
Targeting Altered Energy Metabolism in Colorectal Cancer: Oncogenic Reprogramming, the Central Role of the TCA Cycle and Therapeutic Opportunities
Carina Neitzel et al.
CANCERS (2020)
DNA double-strand breaks induce H2Ax phosphorylation domains in a contact-dependent manner
Patrick L. Collins et al.
NATURE COMMUNICATIONS (2020)
Colorectal cancer in inflammatory bowel disease: review of the evidence
D. S. Keller et al.
TECHNIQUES IN COLOPROCTOLOGY (2019)
Validation of the γH2AX biomarker for genotoxicity assessment: a review
B. Kopp et al.
ARCHIVES OF TOXICOLOGY (2019)
Drugs Targeting Epigenetic Modifications and Plausible Therapeutic Strategies Against Colorectal Cancer
Srinivas Patnaik et al.
FRONTIERS IN PHARMACOLOGY (2019)
The Molecular Hallmarks of the Serrated Pathway in Colorectal Cancer
Fatima Domenica Elisa De Palma et al.
CANCERS (2019)
Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies
NaNa Keum et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
The histone deacetylases HDAC1 and HDAC2 are required for the growth and survival of renal carcinoma cells
Nicole Kiweler et al.
ARCHIVES OF TOXICOLOGY (2018)
Genome instability syndromes caused by impaired DNA repair and aberrant DNA damage responses
Takeshi Terabayashi et al.
CELL BIOLOGY AND TOXICOLOGY (2018)
HDAC1 and HDAC2 integrate checkpoint kinase phosphorylation and cell fate through the phosphatase-2A subunit PR130
Anja Goeder et al.
NATURE COMMUNICATIONS (2018)
From tumour heterogeneity to advances in precision treatment of colorectal cancer
Cornelis J. A. Punt et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Interstrand Crosslink Repair as a Target for HDAC Inhibition
Teodora Nikolova et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2017)
Genomically Incorporated 5-Fluorouracil that Escapes UNG-Initiated Base Excision Repair Blocks DNA Replication and Activates Homologous Recombination
Amelia M. Huehls et al.
MOLECULAR PHARMACOLOGY (2016)
Mechanisms of ATM Activation
Tanya T. Paull
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 84 (2015)
High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response
Hui Gao et al.
NATURE MEDICINE (2015)
Exploiting replicative stress to treat cancer
Matthias Dobbelstein et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
5-Fluorouracil sensitizes colorectal tumor cells towards double stranded DNA breaks by interfering with homologous recombination repair
Upadhyayula Sai Srinivas et al.
ONCOTARGET (2015)
KAP1 Deacetylation by SIRT1 Promotes Non-Homologous End-Joining Repair
Yi-Hui Lin et al.
PLOS ONE (2015)
Histone deacetylase 2 controls p53 and is a critical factor in tumorigenesis
Tobias Wagner et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2014)
Standing the test of time: targeting thymidylate biosynthesis in cancer therapy
Peter M. Wilson et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
Roles of Kruppel-associated Box (KRAB)-associated Co-repressor KAP1 Ser-473 Phosphorylation in DNA Damage Response
Chen Hu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Establishment, Characterization and Chemosensitivity of Three Mismatch Repair Deficient Cell Lines from Sporadic and Inherited Colorectal Carcinomas
Claudia Maletzki et al.
PLOS ONE (2012)
Inhibitors of HDACs - Effective Drugs Against Cancer?
S. Mueller et al.
CURRENT CANCER DRUG TARGETS (2010)
Histone deacetylases 1 and 2 act in concert to promote the G1-to-S progression
Teppei Yamaguchi et al.
GENES & DEVELOPMENT (2010)
Microsatellite instability in colorectal cancer-the stable evidence
Eduardo Vilar et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
HDAC family: What are the cancer relevant targets?
Olaf Witt et al.
CANCER LETTERS (2009)
Participation of DNA repair in the response to 5-fluorouracil
M. D. Wyatt et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2009)
Pharmacokinetically Guided Dose Adjustment of 5-Fluorouracil: A Rational Approach to Improving Therapeutic Outcomes
M. Wasif Saif et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Improved ATM kinase inhibitor KU-60019 radiosensitizes glioma cells, compromises insulin, AKT and ERK prosurvival signaling, and inhibits migration and invasion
Sarah E. Golding et al.
MOLECULAR CANCER THERAPEUTICS (2009)
HDAC2: a critical factor in health and disease
Oliver H. Kraemer
TRENDS IN PHARMACOLOGICAL SCIENCES (2009)
Exploration of the internal cavity of histone deacetylase (HDAC) with selective HDAC1/HDAC2 inhibitors (SHI-1:2)
Joey L. Methot et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
An Inactivating Mutation in HDAC2 Leads to Dysregulation of Apoptosis Mediated by APAF1
Christin L. Hanigan et al.
GASTROENTEROLOGY (2008)
HDAC2 deficiency and histone acetylation
Anne Hansen Ree et al.
NATURE GENETICS (2008)
Histone deacetylase inhibitors and hydroxyurea modulate the cell cycle and cooperatively induce apoptosis
O. H. Kraemer et al.
ONCOGENE (2008)
Mutations in the ataxia telangiectasia and rad3-related-checkpoint kinase I DNA damage response axis in colon cancers
Kriste A. Lewis et al.
GENES CHROMOSOMES & CANCER (2007)
Frequent alteration of DNA damage signalling and repair pathways in human colorectal cancers with microsatellite instability
C. Miquel et al.
ONCOGENE (2007)
ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage
Shuhei Matsuoka et al.
SCIENCE (2007)
ATR-dependent phosphorylation and activation of ATM in response to UV treatment or replication fork stalling
Thomas Stiff et al.
EMBO JOURNAL (2006)
A proposed clinical test for monitoring fluoropyrimidine therapy - Detection and stability of thymidylate synthase ternary complexes
Jonathan R. Brody et al.
CANCER BIOLOGY & THERAPY (2006)
A truncating mutation of HDAC2 in human cancers confers resistance to histone deacetylase inhibition
S Ropero et al.
NATURE GENETICS (2006)
Mutations of an intronic repeat induce impaired MRE11 expression in primary human cancer with microsatellite instability
G Giannini et al.
ONCOGENE (2004)
The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2
OH Krämer et al.
EMBO JOURNAL (2003)
Thymidylate synthase (TS) and ribonucleotide reductase (RNR) may be involved in acquired resistance to 5-fluorouracil (5-FU) in human cancer xenografts in vivo
M Fukushima et al.
EUROPEAN JOURNAL OF CANCER (2001)
Share Paper
